vs

Side-by-side financial comparison of electroCore, Inc. (ECOR) and Marti Technologies, Inc. (MRT). Click either name above to swap in a different company.

Marti Technologies, Inc. is the larger business by last-quarter revenue ($14.6M vs $9.2M, roughly 1.6× electroCore, Inc.). On growth, Marti Technologies, Inc. posted the faster year-over-year revenue change (63.1% vs 31.2%).

electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation.

The Marti Group is a Swiss construction company, consisting of over 80 subsidiaries, officially owned by Marti Holding AG. Besides Switzerland, they are active in neighboring countries such as Germany and Austria, and also outside of Europe such as China and Chile. The company is known for high-profile public and private sector projects and using innovative technologies. Their areas of expertise include building construction, construction and renovation of tunnels, road construction, hydrauli...

ECOR vs MRT — Head-to-Head

Bigger by revenue
MRT
MRT
1.6× larger
MRT
$14.6M
$9.2M
ECOR
Growing faster (revenue YoY)
MRT
MRT
+31.9% gap
MRT
63.1%
31.2%
ECOR

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
ECOR
ECOR
MRT
MRT
Revenue
$9.2M
$14.6M
Net Profit
$-3.0M
Gross Margin
88.4%
49.4%
Operating Margin
-31.8%
-86.1%
Net Margin
-32.8%
Revenue YoY
31.2%
63.1%
Net Profit YoY
6.0%
EPS (diluted)
$-0.34
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECOR
ECOR
MRT
MRT
Q4 25
$9.2M
Q3 25
$8.7M
Q2 25
$7.4M
$14.6M
Q1 25
$6.7M
Q4 24
$7.0M
Q3 24
$6.6M
Q2 24
$6.1M
$8.9M
Q1 24
$5.4M
Net Profit
ECOR
ECOR
MRT
MRT
Q4 25
$-3.0M
Q3 25
$-3.4M
Q2 25
$-3.7M
Q1 25
$-3.9M
Q4 24
$-3.2M
Q3 24
$-2.5M
Q2 24
$-2.7M
Q1 24
$-3.5M
Gross Margin
ECOR
ECOR
MRT
MRT
Q4 25
88.4%
Q3 25
86.0%
Q2 25
87.3%
49.4%
Q1 25
84.9%
Q4 24
85.9%
Q3 24
83.8%
Q2 24
86.3%
Q1 24
83.7%
Operating Margin
ECOR
ECOR
MRT
MRT
Q4 25
-31.8%
Q3 25
-33.2%
Q2 25
-47.5%
-86.1%
Q1 25
-56.9%
Q4 24
-43.6%
Q3 24
-40.4%
Q2 24
-42.2%
-204.1%
Q1 24
-70.7%
Net Margin
ECOR
ECOR
MRT
MRT
Q4 25
-32.8%
Q3 25
-39.2%
Q2 25
-49.7%
Q1 25
-57.4%
Q4 24
-45.8%
Q3 24
-38.1%
Q2 24
-43.2%
Q1 24
-64.4%
EPS (diluted)
ECOR
ECOR
MRT
MRT
Q4 25
$-0.34
Q3 25
$-0.40
Q2 25
$-0.44
$-0.26
Q1 25
$-0.47
Q4 24
$-0.37
Q3 24
$-0.31
Q2 24
$-0.38
$-0.38
Q1 24
$-0.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECOR
ECOR
MRT
MRT
Cash + ST InvestmentsLiquidity on hand
$11.6M
$4.2M
Total DebtLower is stronger
$7.8M
$83.0M
Stockholders' EquityBook value
$-1.7M
$-73.2M
Total Assets
$18.7M
$17.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECOR
ECOR
MRT
MRT
Q4 25
$11.6M
Q3 25
$13.0M
Q2 25
$7.1M
$4.2M
Q1 25
$7.8M
Q4 24
$12.2M
Q3 24
$12.9M
Q2 24
$14.2M
$9.0M
Q1 24
$7.8M
Total Debt
ECOR
ECOR
MRT
MRT
Q4 25
$7.8M
Q3 25
$7.8M
Q2 25
$83.0M
Q1 25
Q4 24
Q3 24
Q2 24
$60.2M
Q1 24
Stockholders' Equity
ECOR
ECOR
MRT
MRT
Q4 25
$-1.7M
Q3 25
$-1.1M
Q2 25
$1.1M
$-73.2M
Q1 25
$4.4M
Q4 24
$7.5M
Q3 24
$9.5M
Q2 24
$11.5M
$-51.2M
Q1 24
$4.5M
Total Assets
ECOR
ECOR
MRT
MRT
Q4 25
$18.7M
Q3 25
$21.4M
Q2 25
$14.6M
$17.2M
Q1 25
$16.0M
Q4 24
$20.5M
Q3 24
$21.0M
Q2 24
$22.4M
$25.0M
Q1 24
$13.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECOR
ECOR
MRT
MRT
Operating Cash FlowLast quarter
$-1.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECOR
ECOR
MRT
MRT
Q4 25
$-1.5M
Q3 25
$-1.7M
Q2 25
$-623.0K
Q1 25
$-4.4M
Q4 24
$-1.3M
Q3 24
$-1.4M
Q2 24
$-1.8M
Q1 24
$-2.6M
Free Cash Flow
ECOR
ECOR
MRT
MRT
Q4 25
Q3 25
$-1.7M
Q2 25
$-648.0K
Q1 25
$-4.4M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
ECOR
ECOR
MRT
MRT
Q4 25
Q3 25
-19.3%
Q2 25
-8.8%
Q1 25
-65.4%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
ECOR
ECOR
MRT
MRT
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.3%
Q1 25
0.6%
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons